Femasys Advances Global Growth with Second Partner Order for FemBloc(R) in Europe
Femasys Advances Global Growth with Second Partner Order for FemBloc(R) in Europe GlobeNewswire November 10, 2025 — Continued rollout of FemBloc, the breakthrough non-surgical permanent contraceptive solution, expands the Company's presence in key European Markets — ATLANTA, Nov. 10, 2025 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical […]